Cargando…
Metabolic Signatures of Cryptosporidium parvum-Infected HCT-8 Cells and Impact of Selected Metabolic Inhibitors on C. parvum Infection under Physioxia and Hyperoxia
SIMPLE SUMMARY: Cryptosporidium parvum is one of the causal agents of cryptosporidiosis. This water-borne disease is responsible for around one million human deaths every year and the only approved anti-cryptosporidial drug for humans, i.e., nitazoxanide, lacks efficacy in immunocompromised patients...
Autores principales: | Vélez, Juan, Velasquez, Zahady, Silva, Liliana M. R., Gärtner, Ulrich, Failing, Klaus, Daugschies, Arwid, Mazurek, Sybille, Hermosilla, Carlos, Taubert, Anja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831031/ https://www.ncbi.nlm.nih.gov/pubmed/33467500 http://dx.doi.org/10.3390/biology10010060 |
Ejemplares similares
-
First Metabolic Insights into Ex Vivo Cryptosporidium parvum-Infected Bovine Small Intestinal Explants Studied under Physioxic Conditions
por: Vélez, Juan, et al.
Publicado: (2021) -
ATP Purinergic Receptor P2X1-Dependent Suicidal NETosis Induced by Cryptosporidium parvum under Physioxia Conditions
por: Hasheminasab, Seyed Sajjad, et al.
Publicado: (2022) -
The Oesophageal Squamous Cell Carcinoma Cell Line COLO-680N Fails to Support Sustained Cryptosporidium parvum Proliferation
por: Vélez, Juan, et al.
Publicado: (2021) -
MCT-Dependent Cryptosporidium parvum-Induced Bovine Monocyte Extracellular Traps (METs) under Physioxia
por: Hasheminasab, Seyed Sajjad, et al.
Publicado: (2023) -
Octaarginine Improves the Efficacy of Nitazoxanide against Cryptosporidium parvum
por: Nguyen-Ho-Bao, Tran, et al.
Publicado: (2022)